Skip to main content

Biotechnology Startups

Updated August 2026

Companies in the biotechnology sector developing innovative solutions and technologies.

Explore 5,740 recently funded biotechnology companies with verified founder contact information and fundraising data.

Total Companies
5,740
Total Funding
$892.6M
Avg Funding
$35.7M
Global Reach
7
countries

Top Cities for Biotechnology

Stockholm
Victoria
Copenhagen
New York
Genk
Piracicaba

Recently Funded Companies

Export
Stockholm, Sweden

EnginZyme is a biotechnology company that creates biomanufacturing techniques for the sustainable production of common goods.

Sep 2024

Founder Contacts

41,000+ verified contacts

Victoria, Canada

Industrial Plankton manufactures algal bioreactors with application in research and aquaculture.

$667K raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.

Sep 2023

Founder Contacts

41,000+ verified contacts

New York, United States

Anvesana develops therapies for treating inheritable blood and bleeding disorders.

$250K raised
Sep 2023

Founder Contacts

41,000+ verified contacts

Genk, Belgium

Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.

$10.7M raised
Sep 2023

Founder Contacts

41,000+ verified contacts

Piracicaba, Brazil

Biotimize is Biotechnology as a Service

$30.0M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Leichhardt, Australia

Evrima transforms the recruitment process for clinical trials to help clinicians accelerate timelines and increase patient awareness.

$2.0M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Calgary, Canada

Syantra is a precision biotechnology company that transforms cancer detection and treatment.

Sep 2025

Founder Contacts

41,000+ verified contacts

Princeton, United States

Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients

Sep 2025

Founder Contacts

41,000+ verified contacts

Baltimore, United States

Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.

$16.0M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

San Antonio, United States

StemBioSys develops proprietary stem cell technologies for the regenerative medicine market.

$72K raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United States

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.

$191.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

ArsenalBio is a programmable cell therapy company that offers CAR T-cell therapies for solid tumors.

$325.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Seattle, United States

Deverra Therapeutics is a biotechnology company that develops allogeneic cellular immunotherapies.

$972K raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

TriptoBIO is a biotechnology research company developing a platform for producing natural plant compounds.

$540K raised
Sep 2023

Founder Contacts

41,000+ verified contacts

Hingham, United States

Sunflower Therapeutics is a biotech company that delivers next-generation protein manufacturing solutions.

$300K raised
Sep 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Angiocrine Bioscience develops a cellular platform to amplify stem and progenitor cells in both human and mouse models.

$2.1M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

$90.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United States

EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease

$5.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Durham, United States

T3D Therapeutics is a company developing remedial therapeutics for Alzheimer’s disease and other CNS disorders.

$6.0M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

$30.0M raised
Sep 2021

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Change Foods is a food-tech company developing animal-free cheese and dairy products.

Sep 2025

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

$6.6M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

Pittsburgh, United States

Renerva is a rapidly-growing and innovative medical device company.

$325K raised
Sep 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.

$175.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Showing 51 to 75 of 5,740 companies

About the Biotechnology Startup Ecosystem

The biotechnology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biotechnology

Biotechnology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biotechnology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biotechnology Funding Breakdown

Here is how funding is distributed among the 5,740 biotechnology companies tracked in the VCBacked database.

Average Funding
$35.7M
Total Funding Tracked
$892.6M
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Biotechnology

1.Copenhagen
3 companies$7.1M
2.New York
2 companies$2.4M
3.Cambridge
2 companies$196.0M
4.Stockholm
1 companiesUndisclosed
5.Victoria
1 companies$667K

Related Industries

Companies in the biotechnology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biotechnology Startups?

Perfect for: B2B sales teams targeting biotechnology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked